- Home
- Publications
- Publication Search
- Publication Details
Title
An update on the CNS manifestations of neurofibromatosis type 2
Authors
Keywords
Neurofibromatosis type 2, Neurofibromatosis type II, NF2, Epidemiology of familial tumor syndromes, Schwannomatosis, Merlin, Schwannomin, ERM (ezrin/radixin/moesin) family scaffolding, Vestibular schwannoma, Meningioma, Glioma, Ependymoma, Neurofibroma, Plexiform schwannoma, Intraneural schwannoma, Cellular schwannoma, Posterior subcapsular lenticular opacities, LZTR1, SH3PXD2A-HTRA1, Verocay body, SUFU, SMARCE1, SMARCB1, Meningioangiomatosis, Glial micro-hamartoma, Glial hamartia, Wishart, Gardner, Von Recklinghausen, Manchester (NIH) Criteria, Manchester Criteria, Schwannoma, Central neurofibromatosis, Neurofibromin 2, Acoustic neuroma
Journal
ACTA NEUROPATHOLOGICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-04
DOI
10.1007/s00401-019-02029-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Assessment of MEK1/2 Inhibitors for Neurofibromatosis Type 2-Associated Schwannomas Reveal Differences in Efficacy and Drug Resistance Development
- (2019) Marisa A Fuse et al. NEURO-ONCOLOGY
- Early history of the different forms of neurofibromatosis from ancient Egypt to the British Empire and beyond: First descriptions, medical curiosities, misconceptions, landmarks, and the persons behind the syndromes
- (2018) Martino Ruggieri et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors
- (2018) Shiyang Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Neurofibromatosis Type 2–Related Eye Disease Correlated With Genetic Severity Type
- (2018) Sally L. Painter et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma
- (2018) Steven P Angus et al. NEURO-ONCOLOGY
- Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury
- (2018) Kristy Truong et al. NEUROSCIENCE
- Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2
- (2018) et al. PLoS One
- Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models
- (2018) Yingchao Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXCR4: A new player in vestibular schwannoma pathogenesis
- (2018) Maria Breun et al. Oncotarget
- A Pediatric Intra-Axial Malignant SMARCB1-Deficient Desmoplastic Tumor Arising in Meningioangiomatosis
- (2018) Sabrina Rossi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Meningioangiomatosis: A review of the variable manifestations and complex pathophysiology
- (2018) Christine Tomkinson et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testing
- (2018) D. Gareth Evans et al. GENETICS IN MEDICINE
- Genetic Severity Score predicts clinical phenotype in NF2
- (2017) Dorothy Halliday et al. JOURNAL OF MEDICAL GENETICS
- Spinal ependymomas in NF2: a surgical disease?
- (2017) M. Kalamarides et al. JOURNAL OF NEURO-ONCOLOGY
- The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma
- (2017) Iddo Paldor et al. JOURNAL OF NEURO-ONCOLOGY
- A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas
- (2017) Stéphane Goutagny et al. JOURNAL OF NEURO-ONCOLOGY
- Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient
- (2017) Andrew T King et al. NEUROSURGERY
- High-Grade Glioma is not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient
- (2017) Andrew T King et al. NEUROSURGERY
- The importance of nerve microenvironment for schwannoma development
- (2016) Alexander Schulz et al. ACTA NEUROPATHOLOGICA
- Methylation-based classification of benign and malignant peripheral nerve sheath tumors
- (2016) Manuel Röhrich et al. ACTA NEUROPATHOLOGICA
- A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2016) J. C. Soria et al. ANNALS OF ONCOLOGY
- Meningioangiomatosis: A Disease With Many Radiological Faces
- (2016) Fábio A. Nascimento et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors
- (2016) Toshio Shimizu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2
- (2016) Blake K. Montgomery et al. CLINICAL NEUROPATHOLOGY
- The genomic landscape of schwannoma
- (2016) Sameer Agnihotri et al. NATURE GENETICS
- Oncogenic PI3K mutations are as common asAKT1andSMOmutations in meningioma
- (2016) Malak Abedalthagafi et al. NEURO-ONCOLOGY
- Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1 -related schwannomatosis
- (2016) Miriam J. Smith et al. NEUROLOGY
- Current status and recommendations for biomarkers and biobanking in neurofibromatosis
- (2016) C. Oliver Hanemann et al. NEUROLOGY
- Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2
- (2015) S. Farschtschi et al. ACTA NEUROLOGICA SCANDINAVICA
- Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
- (2015) Stavros M Stivaros et al. JOURNAL OF MEDICAL GENETICS
- Bilateral vestibular schwannomas in older patients: NF2 or chance?
- (2015) D G Evans et al. JOURNAL OF MEDICAL GENETICS
- Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2
- (2015) Audrey Hochart et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas
- (2015) Stéphane Goutagny et al. JOURNAL OF NEURO-ONCOLOGY
- Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model
- (2015) Xing Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Schwannomas and Their Pathogenesis
- (2014) David A. Hilton et al. BRAIN PATHOLOGY
- Merlin/NF2 Loss-Driven Tumorigenesis Linked to CRL4DCAF1-Mediated Inhibition of the Hippo Pathway Kinases Lats1 and 2 in the Nucleus
- (2014) Wei Li et al. CANCER CELL
- Molecular insights into NF2 /Merlin tumor suppressor function
- (2014) Jonathan Cooper et al. FEBS LETTERS
- Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer
- (2014) Nina R. Shah et al. GYNECOLOGIC ONCOLOGY
- A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation
- (2014) Jeffrey R. Gehlhausen et al. HUMAN MOLECULAR GENETICS
- GermlineSMARCE1mutations predispose to both spinal and cranial clear cell meningiomas
- (2014) Miriam J Smith et al. JOURNAL OF PATHOLOGY
- Evidence of polyclonality in neurofibromatosis type 2–associated multilobulated vestibular schwannomas
- (2014) Ramita Dewan et al. NEURO-ONCOLOGY
- mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma
- (2014) Marco Giovannini et al. NEURO-ONCOLOGY
- Neurofibromatosis Type 2 Vestibular Schwannoma Treatment
- (2014) Anastasios Maniakas et al. OTOLOGY & NEUROTOLOGY
- Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
- (2014) I. M. Shapiro et al. Science Translational Medicine
- Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2
- (2014) Wendy S. Vargas et al. NeuroImage-Clinical
- Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria
- (2013) Scott R. Plotkin et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Schwannomatosis: The Overlooked Neurofibromatosis?
- (2013) Nicholas A. Koontz et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Sporadic meningioangiomatosis: imaging findings with histopathologic correlations in seven patients
- (2013) Tae Yeon Jeon et al. NEURORADIOLOGY
- Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
- (2013) V. E. Clark et al. SCIENCE
- Loss of SUFU Function in Familial Multiple Meningioma
- (2012) Mervi Aavikko et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Hybrid Neurofibroma/Schwannoma is Overrepresented Among Schwannomatosis and Neurofibromatosis Patients
- (2012) Anja Harder et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The role of insulin-like growth factors signaling in merlin-deficient human schwannomas
- (2012) Sylwia Ammoun et al. GLIA
- Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas
- (2012) Christian Hagel et al. NEUROPATHOLOGY
- What Is the Site of Origin of Cochleovestibular Schwannomas?
- (2011) Christof Roosli et al. AUDIOLOGY AND NEURO-OTOLOGY
- Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset
- (2011) M. J. Smith et al. JOURNAL OF MEDICAL GENETICS
- Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients
- (2011) Scott R. Plotkin et al. JOURNAL OF NEUROSURGERY-SPINE
- Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2
- (2011) S. Ammoun et al. NEURO-ONCOLOGY
- Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri
- (2011) Pepijn van den Munckhof et al. NEUROGENETICS
- Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus
- (2010) Wei Li et al. CELL
- Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
- (2010) Ivan Stamenkovic et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
- (2010) Nailing Zhang et al. DEVELOPMENTAL CELL
- Meningiomas and neurofibromatosis
- (2010) Stéphane Goutagny et al. JOURNAL OF NEURO-ONCOLOGY
- Activation of ERK, AKT and JNK signalling pathways in human schwannomasin situ
- (2009) David A Hilton et al. HISTOPATHOLOGY
- NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth
- (2009) M. F. James et al. MOLECULAR AND CELLULAR BIOLOGY
- Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
- (2009) Scott R. Plotkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurofibromatosis type 2 (NF2): A clinical and molecular review
- (2009) D Gareth R Evans Orphanet Journal of Rare Diseases
- Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck region
- (2008) Jena C. Berg et al. HUMAN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now